{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T22:31:26Z","timestamp":1767652286213},"reference-count":40,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2011,6,24]],"date-time":"2011-06-24T00:00:00Z","timestamp":1308873600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0021621","type":"journal-article","created":{"date-parts":[[2011,6,24]],"date-time":"2011-06-24T21:04:48Z","timestamp":1308949488000},"page":"e21621","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":14,"title":["Soluble CD59 Expressed from an Adenovirus In Vivo Is a Potent Inhibitor of Complement Deposition on Murine Liver Vascular Endothelium"],"prefix":"10.1371","volume":"6","author":[{"given":"Jarel","family":"Gandhi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siobhan M.","family":"Cashman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajendra","family":"Kumar-Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2011,6,24]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"715","DOI":"10.2353\/ajpath.2007.070166","article-title":"The role of complement in inflammatory diseases from behind the scenes into the spotlight.","volume":"171","author":"MM Markiewski","year":"2007","journal-title":"Am J Pathol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1016\/j.molimm.2009.04.027","article-title":"The role of the anaphylatoxins in health and disease.","volume":"46","author":"A Klos","year":"2009","journal-title":"Mol Immunol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S1471-4906(01)01972-X","article-title":"Hemolytic uremic syndrome: how do factor H mutants mediate endothelial damage?","volume":"22","author":"PF Zipfel","year":"2001","journal-title":"Trends Immunol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1365-2249.2007.03574.x","article-title":"Translational mini-review series on complement factor H: renal diseases associated with complement factor H: novel insights from humans and animals.","volume":"151","author":"MC Pickering","year":"2008","journal-title":"Clin Exp Immunol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1160\/TH08-09-0575","article-title":"Hereditary and acquired complement dysregulation in membranoproliferative glomerulonephritis.","volume":"101","author":"C Licht","year":"2009","journal-title":"Thromb Haemost"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1161\/CIRCRESAHA.108.191361","article-title":"Complement regulator CD59 protects against atherosclerosis by restricting the formation of complement membrane attack complex.","volume":"104","author":"G Wu","year":"2009","journal-title":"Circ Res"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.preteyeres.2009.11.003","article-title":"The pivotal role of the complement system in aging and age-related macular degeneration: hypothesis re-visited.","volume":"29","author":"DH Anderson","year":"2010","journal-title":"Prog Retin Eye Res"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/S0002-9394(02)01624-0","article-title":"A role for local inflammation in the formation of drusen in the aging eye.","volume":"134","author":"DH Anderson","year":"2002","journal-title":"Am J Ophthalmol"},{"key":"ref9","first-page":"1104","article-title":"Extensive deposits of complement C3d and C5b-9 in the choriocapillaris of eyes of patients with diabetic retinopathy.","volume":"43","author":"VB Gerl","year":"2002","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1097\/00007890-199710270-00006","article-title":"Humoral injury in porcine livers perfused with human whole blood.","volume":"64","author":"S Satoh","year":"1997","journal-title":"Transplantation"},{"key":"ref11","first-page":"754","article-title":"Human decay accelerating factor expressed on endothelial cells of transgenic pigs affects complement activation in an ex vivo liver perfusion model.","volume":"28","author":"A Pascher","year":"1996","journal-title":"Transplant Proc"},{"key":"ref12","article-title":"Role of complement and perspectives for intervention in ischemia-reperfusion damage.","author":"Y Banz","year":"2011"},{"key":"ref13","first-page":"1","article-title":"Human protectin (CD59), an 18,000-20,000 MW complement lysis restricting factor, inhibits C5b-8 catalysed insertion of C9 into lipid bilayers.","volume":"71","author":"S Meri","year":"1990","journal-title":"Immunology"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1084\/jem.170.3.637","article-title":"CD59, an LY-6-like protein expressed in human lymphoid cells, regulates the action of the complement membrane attack complex on homologous cells.","volume":"170","author":"A Davies","year":"1989","journal-title":"J Exp Med"},{"key":"ref15","first-page":"34","article-title":"Recombinant soluble CD59 inhibits reactive haemolysis with complement.","volume":"82","author":"Y Sugita","year":"1994","journal-title":"Immunology"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"48921","DOI":"10.1074\/jbc.M302598200","article-title":"Generation of a recombinant, membrane-targeted form of the complement regulator CD59: activity in vitro and in vivo.","volume":"278","author":"DA Fraser","year":"2003","journal-title":"J Biol Chem"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1002\/1529-0131(200110)44:10<2425::AID-ART407>3.0.CO;2-4","article-title":"Membrane complement regulators protect against the development of type II collagen-induced arthritis in rats.","volume":"44","author":"M Mizuno","year":"2001","journal-title":"Arthritis Rheum"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"33826","DOI":"10.1074\/jbc.M110.153130","article-title":"Recombinant membrane-targeted form of CD59 inhibits the growth of choroidal neovascular complex in mice.","volume":"285","author":"NS Bora","year":"2010","journal-title":"J Biol Chem"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1172\/JCI17348","article-title":"Complement receptor 2-mediated targeting of complement inhibitors to sites of complement activation.","volume":"111","author":"H Song","year":"2003","journal-title":"J Clin Invest"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1172\/JCI4607","article-title":"Targeting of functional antibody-CD59 fusion proteins to a cell surface.","volume":"103","author":"HF Zhang","year":"1999","journal-title":"J Clin Invest"},{"issue":"4","key":"ref21","doi-asserted-by":"crossref","first-page":"e19078","DOI":"10.1371\/journal.pone.0019078","article-title":"A Non Membrane-Targeted Human Soluble CD59 Attenuates Choroidal Neovascularization in a Model of Age Related Macular Degeneration.","volume":"6","author":"SM Cashman","year":"2011","journal-title":"PLoS One"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"4126","DOI":"10.1167\/iovs.08-2025","article-title":"Evaluation of adenovirus-delivered human CD59 as a potential therapy for AMD in a model of human membrane attack complex formation on murine RPE.","volume":"49","author":"K Ramo","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"6776","DOI":"10.1167\/iovs.10-5887","article-title":"Decay accelerating factor (CD55)-mediated attenuation of complement: therapeutic implications for age-related macular degeneration.","volume":"51","author":"KN Ma","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref24","doi-asserted-by":"crossref","DOI":"10.1038\/gt.2011.6","article-title":"Adenovirus-mediated delivery of CD46 attenuates the alternative complement pathway on RPE: implications for age-related macular degeneration.","author":"JH Sweigard","year":"2011"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"5648","DOI":"10.1128\/JVI.00082-09","article-title":"Adenovirus activates complement by distinctly different mechanisms in vitro and in vivo: indirect complement activation by virions in vivo.","volume":"83","author":"J Tian","year":"2009","journal-title":"J Virol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1055\/s-0030-1262888","article-title":"Therapeutic complement inhibition: new developments.","volume":"36","author":"W Emlen","year":"2010","journal-title":"Semin Thromb Hemost"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"3478","DOI":"10.4049\/jimmunol.144.9.3478","article-title":"The complement-inhibitory activity of CD59 resides in its capacity to block incorporation of C9 into membrane C5b-9.","volume":"144","author":"SA Rollins","year":"1990","journal-title":"J Immunol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1128\/JCM.36.8.2342-2345.1998","article-title":"Characterization of Neisseria meningitidis strains causing disease in complement-deficient and complement-sufficient patients.","volume":"36","author":"CA Fijen","year":"1998","journal-title":"J Clin Microbiol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1086\/515075","article-title":"Assessment of complement deficiency in patients with meningococcal disease in The Netherlands.","volume":"28","author":"CA Fijen","year":"1999","journal-title":"Clin Infect Dis"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1136\/gut.40.4.544","article-title":"Acquired C3 deficiency in patients with alcoholic cirrhosis predisposes to infection and increased mortality.","volume":"40","author":"C Homann","year":"1997","journal-title":"Gut"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/ni.1923","article-title":"Complement: a key system for immune surveillance and homeostasis.","volume":"11","author":"D Ricklin","year":"2010","journal-title":"Nat Immunol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1097\/01.WCB.0000046146.31247.A1","article-title":"Neuroprotection by complement (C1) inhibitor in mouse transient brain ischemia.","volume":"23","author":"MG De Simoni","year":"2003","journal-title":"J Cereb Blood Flow Metab"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"13282","DOI":"10.1073\/pnas.241506298","article-title":"Lifetime correction of genetic deficiency in mice with a single injection of helper-dependent adenoviral vector.","volume":"98","author":"IH Kim","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1089\/hum.2006.17.1262","article-title":"Differential biodistribution of adenoviral vector in vivo as monitored by bioluminescence imaging and quantitative polymerase chain reaction.","volume":"17","author":"M Johnson","year":"2006","journal-title":"Hum Gene Ther"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.4049\/jimmunol.158.4.1692","article-title":"Molecular cloning, chromosomal localization, expression, and functional characterization of the mouse analogue of human CD59.","volume":"158","author":"MB Powell","year":"1997","journal-title":"J Immunol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/ajh.21319","article-title":"Generation and phenotyping of mCd59a and mCd59b double-knockout mice.","volume":"84","author":"X Qin","year":"2009","journal-title":"Am J Hematol"},{"key":"ref37","first-page":"843","article-title":"Association of murine CD31 with transmigrating lymphocytes following antigenic stimulation.","volume":"141","author":"SA Bogen","year":"1992","journal-title":"Am J Pathol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1038\/sj.mt.6300203","article-title":"Improved retinal transduction in vivo and photoreceptor-specific transgene expression using adenovirus vectors with modified penton base.","volume":"15","author":"SM Cashman","year":"2007","journal-title":"Mol Ther"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1073\/pnas.95.5.2509","article-title":"A simplified system for generating recombinant adenoviruses.","volume":"95","author":"TC He","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1089\/hum.1996.7.2-215","article-title":"Characterization of 911: a new helper cell line for the titration and propagation of early region 1-deleted adenoviral vectors.","volume":"7","author":"FJ Fallaux","year":"1996","journal-title":"Hum Gene Ther"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0021621","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,7]],"date-time":"2023-06-07T17:58:01Z","timestamp":1686160681000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0021621"}},"subtitle":[],"editor":[{"given":"Aernout","family":"Luttun","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2011,6,24]]},"references-count":40,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2011,6,24]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0021621","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,6,24]]}}}